🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, asserting the companies concealed potential risks that the pain reliever posed to pediatric neurological development.

This legal action comes thirty days after President Donald Trump promoted an unsubstantiated connection between consuming acetaminophen - referred to as paracetamol - throughout gestation and autism in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a official comment, he stated they "misled consumers by profiting off of suffering and marketing drugs ignoring the dangers."

Kenvue says there is lacking scientific proof linking Tylenol to autism.

"These manufacturers lied for decades, deliberately risking countless individuals to line their pockets," the attorney general, a Republican, said.

Kenvue stated officially that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its online platform, the company also mentioned it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a verified association between using acetaminophen and autism spectrum disorder."

Groups acting on behalf of physicians and healthcare providers agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in acetaminophen - is one of the few options for pregnant women to treat discomfort and fever, which can present major wellness concerns if not addressed.

"In multiple decades of investigation on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the use of paracetamol in any stage of gestation leads to brain development issues in young ones," the group commented.

This legal action cites latest statements from the Trump administration in claiming the drug is allegedly unsafe.

Last month, Trump caused concern from public health officials when he instructed women during pregnancy to "resist strongly" not to use acetaminophen when unwell.

The FDA then published an announcement that doctors should think about restricting the usage of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in young ones has remains unverified.

Health Secretary Kennedy, who supervises the FDA, had pledged in April to conduct "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a matter of months.

But authorities cautioned that identifying a sole reason of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and disability that influences how individuals perceive and engage with the surroundings, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is campaigning for the Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "eliminate any marketing or advertising" that claims Tylenol is reliable for pregnant women.

This legal action parallels the grievances of a assembly of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022.

Judicial authorities threw out the legal action, stating investigations from the parents' expert witnesses was inconclusive.